More importantly, the increase in ADCY6 reversed the promoting effect of miR-27a-3p overexpression on the malignant biological behaviour of breast cancer cells and reduced the expression of EMT-related proteins that had been increased by miR-27a-3p. The gene discussed is ADCY6; the disease is breast carcinoma.